Form 8.3 - AON PLC
BARCLAYS PLC
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) |
Barclays PLC. |
Company dealt in |
AON PLC |
Class of relevant security to which the dealings being disclosed relate (Note 2) |
ORD |
Date of dealing |
23 September 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) |
Relevant securities | ||||
384,662 |
0.17% |
2,449,411 |
1.06% |
||
(2) |
Derivatives (other than options): | ||||
530,855 |
0.23% |
28,200 |
0.01% |
||
(3) |
Options and agreements to | ||||
purchase/sell: |
106,599 |
0.05% |
106,599 |
0.05% |
|
TOTAL: | |||||
1,022,116 |
0.44% |
2,584,210 |
1.12% |
||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: |
Long |
Short |
||||
|
Number |
|
(%) |
Number |
|
(%) |
(1) Relevant securities |
|
|
||||
(2) Derivatives (other than options) |
|
|
||||
(3) Options and agreements to purchase/sell |
|
|
||||
Total |
|
|
||||
|
Ap20
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase |
1 |
200.7200 USD |
Purchase |
21 |
204.0100 USD |
Purchase |
80 |
202.6700 USD |
Purchase |
100 |
205.0000 USD |
Purchase |
100 |
201.6500 USD |
Purchase |
101 |
202.0099 USD |
Purchase |
200 |
201.4400 USD |
Purchase |
200 |
201.4750 USD |
Purchase |
310 |
201.9277 USD |
Purchase |
346 |
204.4769 USD |
Purchase |
486 |
202.5992 USD |
Purchase |
500 |
203.5660 USD |
Purchase |
515 |
203.2508 USD |
Purchase |
700 |
203.9000 USD |
Purchase |
800 |
202.2600 USD |
Purchase |
1,711 |
201.9634 USD |
Purchase |
2,259 |
202.1325 USD |
Purchase |
4,202 |
203.5058 USD |
Purchase |
4,333 |
200.4100 USD |
Purchase |
4,497 |
202.2009 USD |
Purchase |
8,723 |
202.1362 USD |
Purchase |
9,402 |
202.0676 USD |
Purchase |
19,600 |
202.4542 USD |
Purchase |
38,880 |
202.7792 USD |
Purchase |
52,619 |
203.3557 USD |
Purchase |
53,352 |
200.4580 USD |
Sale |
11 |
203.7972 USD |
Sale |
12 |
201.6600 USD |
Sale |
21 |
204.0100 USD |
Sale |
66 |
203.7200 USD |
Sale |
76 |
202.4555 USD |
Sale |
88 |
203.7100 USD |
Sale |
100 |
200.6425 USD |
Sale |
100 |
200.3700 USD |
Sale |
100 |
203.6500 USD |
Sale |
100 |
201.6500 USD |
Sale |
200 |
201.4750 USD |
Sale |
242 |
203.2638 USD |
Sale |
311 |
203.2295 USD |
Sale |
322 |
203.5777 USD |
Sale |
368 |
203.8024 USD |
Sale |
369 |
203.3652 USD |
Sale |
425 |
203.4755 USD |
Sale |
526 |
203.5281 USD |
Sale |
567 |
203.4346 USD |
Sale |
904 |
203.6902 USD |
Sale |
1,200 |
203.5187 USD |
Sale |
1,573 |
202.9043 USD |
Sale |
1,625 |
202.8013 USD |
Sale |
1,846 |
200.4101 USD |
Sale |
2,001 |
204.9978 USD |
Sale |
2,300 |
203.0804 USD |
Sale |
2,600 |
201.0276 USD |
Sale |
2,959 |
202.9842 USD |
Sale |
3,048 |
202.7964 USD |
Sale |
3,355 |
203.1041 USD |
Sale |
3,700 |
203.2786 USD |
Sale |
3,700 |
201.7720 USD |
Sale |
4,014 |
202.9252 USD |
Sale |
4,478 |
203.1693 USD |
Sale |
5,100 |
203.0524 USD |
Sale |
5,703 |
202.2591 USD |
Sale |
6,658 |
203.6882 USD |
Sale |
7,101 |
201.5204 USD |
Sale |
10,800 |
201.9123 USD |
Sale |
11,262 |
203.0739 USD |
Sale |
22,642 |
202.5614 USD |
Sale |
27,059 |
200.6029 USD |
Sale |
29,344 |
200.4100 USD |
Sale |
33,526 |
203.4079 USD |
Sale |
38,880 |
202.7792 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD |
Nature of transaction (Note 6) |
Number of relevant securities (Note 7) |
Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option |
Writing, selling, purchasing, varying etc. |
Number of securities to which the option relates (Note 7) |
Exercise price |
Type, e.g. American, European etc. |
Expiry date |
Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option |
Number of securities |
Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) |
Details |
Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 attached? (Note 9) YES
Date of disclosure |
24 September 2020 |
Contact name |
Large Holdings Regulatory Operations |
Telephone number |
020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected |
|
If a connected EFM, state nature of connection (Note 10) |
|
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name | Written or | Number of | Exercise | Type | Expiry |
purchased | relevant securities | price | date | ||
to which the option | |||||
or derivative | |||||
relates | |||||
Put Options | Purchased |
-106,599 |
214.5780 |
European |
Oct 20, 2020 |
Put Options | Written |
106,599 |
214.5780 |
European |
Oct 20, 2020 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200924005427/en/